This month, Alabama's bioscience industry will hold a conference

This month, Alabama's bioscience industry will hold a conference ...

JLABs, the global head of innovation, will conduct the first in-person meeting for members of Alabama's bioscience industry later this month.

On April 25, Melinda Richter will conduct a keynote at BIO Alabama, the company's biosciences trade division, and will feature speakers from around the country on topics ranging from state innovation economies to workforce challenges.

The event, "Building Alabama's Biohorizons," will feature about 200 scientists. For more information, please contact us.

Richter is the lead author of an external Johnson & Johnson research and development engine that works with over 700 companies around the world in biopharm, medical equipment, and health tech arenas.

"Having a global company like Johnson & Johnson invest in the vision for Alabama's future in bioscience gives our bioeconomy a head start for long-term strategic growth," says BIO Alabama CEO Rachel Lane.

Will Rosellini, the cofounder and president of CytoImmune Therapeutics, the company that develops immunotherapies, will also give a keynote address on the importance of nondilutive capital in the innovation economy.

Lane said the conference will bring together the state's bioscience community to discuss a strategy for expanding the industry.

"Alabama has a long history in bioscience innovation, but we do not have a cohesive path forward that is capable of exceeding all of our resources and potential," Lane said.

BIO Alabama is partnering with the Alabama Department of Commerce to host its first-ever statewide reverse-pitch event for the state's bioscience research institutes.

The Grand Bohemian will be open to bioscience businesses from 2 to 17 p.m. on April 26. It will focus on research and development and to speed innovation.

Auburn University, HudsonAlpha Institute for Biotechnology, Southern Research, Tuskegee University, UAB, and the University of South Alabama are all presenting technologies to industry partners, with over thirty-five potential technology matches.

Local corporations, like CFD Research in Huntsville, national names, including Rhodium Scientific in Texas and Avanos Medical in Georgia, and international corporations, such as Johnson & Johnson, Evonik, MilliporeSigma, and Croda International are among the industry participants.

These collaborations result in a sustained expansion of research so that it may reach patients and end users more quickly, Lane said. They also support startup development, job creation, a positive innovation environment, and additional capital access opportunities.

You may also like: